Skip to main content
SpringerLink
Log in

PATENTS

Evidence-based obviousness for use in patent prosecution and review

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A process for the non-arbitrary determination of obviousness based on examining actual patenting practices of large groups could improve outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2: The date of first disclosure of a deuterated drug patent application by the peer group.

References

  1. US Patent and Trademark Office. Trial Statistics: IPR, PGR, CBM. Patent Trial and Appeal Board, May 2017, https://www.uspto.gov/sites/default/files/documents/Trial_Statistics_2017–05–31.pdf (2017).

  2. Carter, J. R. Houst. Law Rev. 54, 1315–1348 (2016).

    Google Scholar 

  3. Schuster, W. M. Mich. Telecommun. Technol. Law Rev. 22, 281–286 (2015).

    Google Scholar 

  4. Shepherd, J. NYU J. Intell. Prop. Ent. L. 6, 14–46 (2016).

    Google Scholar 

  5. U.S. Code Title 35—Inter Partes Review, https://www.govinfo.gov/content/pkg/USCODE-2012-title35/pdf/USCODE-2012-title35-partIII-chap31.pdf.

  6. McAllister, R.B. & Vandlen, C.E. Cornell HR Rev. http://digitalcommons.ilr.cornell.edu/chrr/17 (2010).

  7. Mullard, A. Nat. Rev. Drug Discov. 15, 219–221 (2016).

    Article  CAS  Google Scholar 

  8. Schmidt, C. Nat. Biotechnol. 35, 493–494 (2017).

    Article  CAS  Google Scholar 

  9. Timmins, G. S. Expert Opin. Ther. Pat. 24, 1067–1075 (2014).

    Article  CAS  Google Scholar 

  10. Harbeson, S. L. et al. J. Pharmacol. Exp. Ther. 362, 359–367 (2017).

    Article  CAS  Google Scholar 

  11. Srivastava, K. et al. Patient Prefer. Adherence 7, 419–434 (2013).

    PubMed  PubMed Central  Google Scholar 

  12. Reinhold, D.F. US Patent 3,950,411 (1976).

  13. McCarty, L.P. US Patent 4,069,346 (1978).

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

    Graham S. Timmins

Authors
  1. Graham S. Timmins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Graham S. Timmins.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Timmins, G.S. Evidence-based obviousness for use in patent prosecution and review. Nat Biotechnol 37, 997–1000 (2019). https://doi.org/10.1038/s41587-019-0232-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-019-0232-x

  • Springer Nature America, Inc.

Search

Navigation